Yuling Luo insider trades

Open-market stock purchases and sales by Yuling Luo, Chief Executive Officer at Alamar Biosciences, Inc, from SEC Form 4 filings since Apr 16, 2026.

Recent trades

DateStockTradeValue
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 20, 2026ALMR Alamar Biosciences, IncBought (not open market)—
Apr 16, 2026ALMR Alamar Biosciences, IncBought (not open market)—

Companies traded

  • ALMR Alamar Biosciences, Inc: other filings, last Apr 20, 2026

Get free alerts when Yuling Luo files a new trade →